"NeuroStudies is an experienced, clinical research group dedicated to the development of safe and effective treatments to help prevent memory loss and dementia for patients around the world. With secure, modern facilities and a committed staff, we not only remain on the forefront of medical and technology advancements, but also provide our patients and study participants with the best clinical trial experience possible. Our team works around-the-clock to help ensure patients are receiving the highest standard of care, and are well-informed, comfortable and safe."

During the past decade, NeuroStudies conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NeuroStudies" #1 sponsor was "Pfizer" with 3 trials, followed by "TauRx Therapeutics Ltd" with 2 trials sponsored, "Alector Inc." with 1 trials sponsored, "Alzheon Inc." with 1 trials sponsored and "Cognito Therapeutics, Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "NeuroStudies" #1 collaborator was "National Institute on Aging (NIA)" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Banner Alzheimer's Institute" with 1 trials as a collaborator and "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "NeuroStudies" are "Alzheimer Disease" (5 trials), "Alzheimer Disease, Early Onset" (2 trials), "Alzheimer's Disease" (2 trials), "Alzheimer Disease 1" (1 trials) and "Alzheimer Disease 10" (1 trials). Many other conditions were trialed in "NeuroStudies" in a lesser frequency.

Most popular intervention types in "NeuroStudies" are "Drug" (11 trials), "Biological" (1 trials), "Combination Product" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "bapineuzumab" (3 trials), "Placebo" (2 trials), "placebo" (2 trials), "AD-35 60mg group" (1 trials) and "AL002" (1 trials). Other intervention names were less common.

The vast majority of trials in "NeuroStudies" are 12 trials for "All" genders.

Currently, there are NaN active trials in "NeuroStudies". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in NeuroStudies, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in NeuroStudies, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

NeuroStudies has several departments that took part in Clinical trials: "NeuroStudies.net, LLC" - 23 trials